17 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Pathophysiology: 1. ... Tuberculosis: 1. ... involvement - seeding ... Tuberculosis Treatment ... Initiating Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Pathophysiology: 1. ... Tuberculosis: 1. ... involvement - seeding ... Tuberculosis Treatment ... Initiating Treatment
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... screen within 1 ... 0.5mL IM at 0, 1– ... #Prevention #Treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
for Treating Mucosal ... 4–6 mL QID or 1– ... #Candidiasis #candida ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Tuberculosis Infection ... for active or latent ... #IDSA #Prevention ... #HIVAIDS #pharmacology
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Epidemiology: • #1 ... nosocomial infection ... 10 mg/kg IV x 1 ... mg PO qd - If needing ... #gastroenterology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... Preventing and Treating ... #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #management
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... are contacts of infectious ... Step 1: Choose one ... antimicrobials #regimens #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... • Valacyclovir 1 ... • Valacyclovir 1 ... • Continue treatment ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... mg/kg on days 1– ... Leishmaniasis #Prevention #Treatment ... opportunistic #infections ... #HIVAIDS #pharmacology